Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study

Eloy José Tarín-Vicente, Andrea Alemany, Manuel Agud-Dios, Maria Ubals, Clara Suñer, Andrés Antón, Maider Arando, Jorge Arroyo-Andrés, Lorena Calderón-Lozano, Cristina Casañ, José Miguel Cabrera, Pep Coll, Vicente Descalzo, María Dolores Folgueira, Jorge N García-Pérez, Elena Gil-Cruz, Borja González-Rodríguez, Christian Gutiérrez-Collar, Águeda Hernández-Rodríguez, Paula López-Roa, María de Los Ángeles Meléndez, Julia Montero-Menárguez, Irene Muñoz-Gallego, Sara Isabel Palencia-Pérez, Roger Paredes, Alfredo Pérez-Rivilla, María Piñana, Nuria Prat, Aída Ramirez, Ángel Rivero, Carmen Alejandra Rubio-Muñiz, Martí Vall, Kevin Stephen Acosta-Velásquez, An Wang, Cristina Galván-Casas, Michael Marks, Pablo L Ortiz-Romero, Oriol Mitjà, Eloy José Tarín-Vicente, Andrea Alemany, Manuel Agud-Dios, Maria Ubals, Clara Suñer, Andrés Antón, Maider Arando, Jorge Arroyo-Andrés, Lorena Calderón-Lozano, Cristina Casañ, José Miguel Cabrera, Pep Coll, Vicente Descalzo, María Dolores Folgueira, Jorge N García-Pérez, Elena Gil-Cruz, Borja González-Rodríguez, Christian Gutiérrez-Collar, Águeda Hernández-Rodríguez, Paula López-Roa, María de Los Ángeles Meléndez, Julia Montero-Menárguez, Irene Muñoz-Gallego, Sara Isabel Palencia-Pérez, Roger Paredes, Alfredo Pérez-Rivilla, María Piñana, Nuria Prat, Aída Ramirez, Ángel Rivero, Carmen Alejandra Rubio-Muñiz, Martí Vall, Kevin Stephen Acosta-Velásquez, An Wang, Cristina Galván-Casas, Michael Marks, Pablo L Ortiz-Romero, Oriol Mitjà

Abstract

Background: In May, 2022, several European countries reported autochthonous cases of monkeypox, which rapidly spread globally. Early reports suggest atypical presentations. We aimed to investigate clinical and virological characteristics of cases of human monkeypox in Spain.

Methods: This multicentre, prospective, observational cohort study was done in three sexual health clinics in Madrid and Barcelona, Spain. We enrolled all consecutive patients with laboratory-confirmed monkeypox from May 11 to June 29, 2022. Participants were offered lesion, anal, and oropharynx swabs for PCR testing. Participant data were collected by means of interviews conducted by dermatologists or specialists in sexually transmitted infections and were recorded using a standard case report form. Outcomes assessed in all participants with a confirmed diagnosis were demographics, smallpox vaccination, HIV status, exposure to someone with monkeypox, travel, mass gathering attendance, risk factors for sexually transmitted infections, sexual behaviour, signs and symptoms on first presentation, virological results at multiple body sites, co-infection with other sexually transmitted pathogens, and clinical outcomes 14 days after the initial presentation. Clinical outcomes were followed up until July 13, 2022.

Findings: 181 patients had a confirmed monkeypox diagnosis and were enrolled in the study. 166 (92%) identified as gay men, bisexual men, or other men who have sex with men (MSM) and 15 (8%) identified as heterosexual men or heterosexual women. Median age was 37·0 years (IQR 31·0-42·0). 32 (18%) patients reported previous smallpox vaccination, 72 (40%) were HIV-positive, eight (11%) had a CD4 cell count less than 500 cells per μL, and 31 (17%) were diagnosed with a concurrent sexually transmitted infection. Median incubation was 7·0 days (IQR 5·0-10·0). All participants presented with skin lesions; 141 (78%) participants had lesions in the anogenital region, and 78 (43%) in the oral and perioral region. 70 (39%) participants had complications requiring treatment: 45 (25%) had a proctitis, 19 (10%) had tonsillitis, 15 (8%) had penile oedema, six (3%) an abscess, and eight (4%) had an exanthem. Three (2%) patients required hospital admission. 178 (99%) of 180 swabs from skin lesions collected tested positive, as did 82 (70%) of 117 throat swabs. Viral load was higher in lesion swabs than in pharyngeal specimens (mean cycle threshold value 23 [SD 4] vs 32 [6], absolute difference 9 [95% CI 8-10]; p<0·0001). 108 (65%) of 166 MSM reported anal-receptive sex. MSM who engaged in anal-receptive sex presented with proctitis (41 [38%] of 108 vs four [7%] of 58, absolute difference 31% [95% CI 19-44]; p<0·0001) and systemic symptoms before the rash (67 [62%] vs 16 [28%], absolute difference 34% [28-62]; p<0·0001) more frequently than MSM who did not engage in anal-receptive sex. 18 (95%) of 19 participants with tonsillitis reported practising oral-receptive sex. The median time from onset of lesions to formation of a dry crust was 10 days (IQR 7-13).

Interpretation: In our cohort, monkeypox caused genital, perianal, and oral lesions and complications including proctitis and tonsillitis. Because of the variability of presentations, clinicians should have a low threshold for suspicion of monkeypox. Lesion swabs showed the highest viral loads, which, combined with the history of sexual exposure and the distribution of lesions, suggests close contact is probably the dominant transmission route in the current outbreak.

Funding: None.

Conflict of interest statement

Declaration of interests We declare no competing interests.

Copyright © 2022 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
Clinical presentation of monkeypox (A) Pustules in the genital and pubic region, in which the initial umbilication has progressed to necrotic crust with central depression. (B) Three semiconfluent pustular lesions with a depressed centre located on the left side of the tongue dorsum. (C) Pearly acral vesicles embedded in the thick stratum corneum of the palmar skin, shotty on palpation. (D) Scattered papules, pustules, and umbilicated pustules surrounded by an erythematous halo on the lateral aspect of the chest and left arm. (E) Pustules circumferentially distributed on the anal margin and perianal skin. (F) A pustular lesion with a crusted centre on the semimucosa of the lower lip, close to the right oral commissure. (G) Primary inoculation site with a large, crusted lesion on the right cheek. (H) The right palatine tonsil is reddened and enlarged and has a fibrin-covered ulcer. (I) The penile glans and foreskin have lesions of varying sizes and stages of evolution, with oedema surrounding the larger ulcer. Pictures A–C, E–G, and I were taken by EJT-V; pictures D and H were taken by MU.
Figure 2
Figure 2
Mean cycle threshold values by swab location and location of skin lesions and incubation periods by presumed route of infection (A) Mean cycle threshold values as a proxy for viral load for lesional swabs compared with pharynx swabs. (B) Location of skin lesions by presumed route of infection. (C) Incubation period of monkeypox by presumed route of infection and location of lesions. MSM=men who have sex with men.

References

    1. UK Health Security Agency Investigation into monkeypox outbreak in England: technical briefing 1. 2022.
    1. WHO Multi-country monkeypox outbreak in non-endemic countries: update. 2022.
    1. European Centre for Disease Prevention and Control Epidemiological update: monkeypox multi-country outbreak. 2022.
    1. Damon IK. In: Fields virology. Knipe DM, Howley PM, editors. Lippincott Williams & Wilkins, a Wolters Kluwer business; Philadephia, PA: 2013. Poxviruses; pp. 2160–2184.
    1. Dixon CW. J & A Churchill; London: 1962. Smallpox.
    1. Elwood JM. Smallpox and its eradication. J Epidemiol Community Health. 1989;43:92.
    1. Ogoina D, Iroezindu M, James HI, et al. Clinical course and outcome of human monkeypox in Nigeria. Clin Infect Dis. 2020;71:e210–e214.
    1. Reynolds MG, Carroll DS, Karem KL. Factors affecting the likelihood of monkeypox's emergence and spread in the post-smallpox era. Curr Opin Virol. 2012;2:335–343.
    1. Huhn GD, Bauer AM, Yorita K, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41:1742–1751.
    1. Learned LA, Reynolds MG, Wassa DW, et al. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg. 2005;73:428–434.
    1. Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22:1153–1162.
    1. Yinka-Ogunleye A, Aruna O, Dalhat M, et al. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report. Lancet Infect Dis. 2019;19:872–879.
    1. Reynolds MG, Yorita KL, Kuehnert MJ, et al. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis. 2006;194:773–780.
    1. Rao A, Bachmann LH, Petersen B. What clinicians need to know about monkeypox in the United States and other countries. In: Clinician Outreach and Communication Activity webinar. 2022.
    1. Buenestado-Serrano S, Palomino-Cabrera R, Peñas-Utrilla D, et al. Second draft genome from Spain of the monkeypox virus 2022 outbreak. Genome Reports.
    1. Instituto de Salud Carlos III Genomic analysis of monkeypox samples from 23 patients. 2022.
    1. Girometti N, Byrne R, Bracchi M, et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational study. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00411-X. published online July 1.
    1. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med. 2022 doi: 10.1056/NEJMoa2207323. published online July 21.
    1. Patel A, Bilinska J, Tam JCH, et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series. BMJ. 2022;378
    1. Brothwell JA, Griesenauer B, Chen L, Spinola SM. Interactions of the skin pathogen Haemophilus ducreyi with the human host. Front Immunol. 2021;11
    1. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28:1509–1519.
    1. Buller RMPG, Palumbo GJ. Poxvirus pathogenesis. Microbiol Rev. 1991;55:80–122.
    1. Chapman JL, Nichols DK, Martinez MJ, Raymond JW. Animal models of orthopoxvirus infection. Vet Pathol. 2010;47:852–870.
    1. MacLeod DT, Nakatsuji T, Wang Z, di Nardo A, Gallo RL. Vaccinia virus binds to the scavenger receptor MARCO on the surface of keratinocytes. J Invest Dermatol. 2015;135:142–150.
    1. Liu L, Xu Z, Fuhlbrigge RC, Peña-Cruz V, Lieberman J, Kupper TS. Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J Virol. 2005;79:7363–7370.
    1. Mitchell H, Hughes G. Recent epidemiology of sexually transmissible enteric infections in men who have sex with men. Curr Opin Infect Dis. 2018;31:50–56.

Source: PubMed

3
Abonner